CD69 and neoplasm: In addition, Met@Man-MPs markedly increased the numbers of CD8+ T (Fig. 6d), CD8+CD69+ T (Fig. 6e), and CD8+IFN-γ+ T cells (Fig. 6f) in tumor tissues by flow cytometry.